Compare ENR & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ENR | ZLAB |
|---|---|---|
| Founded | 2015 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 2.0B |
| IPO Year | N/A | 2017 |
| Metric | ENR | ZLAB |
|---|---|---|
| Price | $19.99 | $17.26 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 6 |
| Target Price | $27.00 | ★ $57.22 |
| AVG Volume (30 Days) | ★ 1.2M | 843.4K |
| Earning Date | 02-03-2026 | 11-06-2025 |
| Dividend Yield | ★ 6.02% | N/A |
| EPS Growth | ★ 538.46 | N/A |
| EPS | ★ 3.32 | N/A |
| Revenue | ★ $2,952,700,000.00 | $441,629,000.00 |
| Revenue This Year | $2.65 | $26.16 |
| Revenue Next Year | $1.09 | $30.62 |
| P/E Ratio | $6.00 | ★ N/A |
| Revenue Growth | 2.28 | ★ 24.14 |
| 52 Week Low | $16.77 | $16.82 |
| 52 Week High | $35.90 | $44.34 |
| Indicator | ENR | ZLAB |
|---|---|---|
| Relative Strength Index (RSI) | 48.30 | 32.86 |
| Support Level | $19.55 | $17.18 |
| Resistance Level | $20.50 | $17.97 |
| Average True Range (ATR) | 0.62 | 0.60 |
| MACD | 0.13 | 0.22 |
| Stochastic Oscillator | 22.63 | 21.00 |
Energizer Holdings Inc makes and distributes household batteries, specialty batteries, and lighting products. Energizer offers batteries using lithium, alkaline, carbon-zinc, nickel-metal hydride, zinc-air, and silver oxide technologies. These products are sold under the Energizer, Rayovac, Varta and Eveready brands at performance and premium price segments. It also offers auto care products in the appearance, fragrance, performance, and air conditioning recharge product categories. The company operates in two geographical segments: Americas and International, of which the majority of its revenue is derived from the America. It has two product segments: Batteries & Lights and Auto Care. It earns maximum revenue from Batteries & Lights segment.
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.